MedTrace Logo

When and How to Administer Oxytocin for Active Management of Third Stage of Labour

NCT01954186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2013-10-01

No results posted yet for this study

Summary

To compare the efficacy of the route and timing of oxytocin administration for Active management of third stage of labour (AMTSL).

Conditions

  • Postpartum Bleeding

Interventions

DRUG

intravenous & intramuscular oxytocin

intravenous or intramuscular 10 iu oxytocin

PROCEDURE

after delivery of the fetus & when anterior shoulder seen

oxytocin 10 iu after the delivery of the fetus or when the anterior shoulder was seen after the fetal head was delivered

Sponsors & Collaborators

  • Etlik Zubeyde Hanim Womens' Health and Teaching Hospital

    lead UNKNOWN

Principal Investigators

  • Berna DILBAZ, Assoc. Prof. · Etlik Zübeyde Hanım Women's Health Teaching and Research Hospital, Obstetrics and Gynecology, Ankara, Turkey ,

  • Emire OGUZ ORHAN, MD · Sivas State Hospital

  • Sezin ERTURK AKSAKAL, MD · Etlik Zübeyde Hanım Women's Health Teaching and Research Hospital, Obstetrics and Gynecology, Ankara, Turkey

  • Sibel ALTINBAS, Assist. Prof. · Hacettepe University Kastamonu Medical Faculty, Obstetrics and Gynecology, Ankara, Turkey,

  • Salim ERKAYA, Assoc. Prof. · Zekai Tahir Burak Maternity and Teaching Hospital, Obstetrics and Gynecology, Ankara, Turkey

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01954186 on ClinicalTrials.gov